Copyright
©The Author(s) 2020.
World J Clin Cases. May 26, 2020; 8(10): 1859-1870
Published online May 26, 2020. doi: 10.12998/wjcc.v8.i10.1859
Published online May 26, 2020. doi: 10.12998/wjcc.v8.i10.1859
Table 1 Gender distribution, clinical appearance and average stenosis rate in patients with carotid artery stenosis
Characteristic | n | % | |
Gender | Female | 17 | 26.6 |
Male | 47 | 73.4 | |
Clinical appearance | Asymptomatic | 12 | 18.8 |
Symptomatic | 52 | 81.2 | |
Average stenosis rate | Asymptomatic | - | 68.33 |
Symptomatic | - | 74.69 |
Table 2 Accompanying comorbid diseases and risk factors for cases with carotid artery stenosis
Comorbid diseases and risk factors | n | % |
Hypertension | 38 | 30.2 |
Diabetes mellitus | 22 | 17.5 |
Cerebrovascular disease | 20 | 15.9 |
Coronary artery disease | 15 | 11.9 |
Hyperlipidemia | 9 | 7.1 |
Smoking | 8 | 6.3 |
Goiter | 5 | 4.0 |
Chronic obstructive pulmonary disease | 4 | 3.2 |
Congestive heart failure | 2 | 1.6 |
Asthma | 1 | 0.8 |
Glaucoma | 1 | 0.8 |
Familial mediterranean fever | 1 | 0.8 |
Table 3 Side and location of carotid artery stenosis and distribution of atherosclerotic plaque morphology
Parameters | n | % | |
Side of stenosis | Right | 33 | 51.6 |
Left | 31 | 48.4 | |
Location of stenosis | CCA distal and ICA bulb | 6 | 9.3 |
ICA bulb | 42 | 65.6 | |
Dissection of ICA bulb | 1 | 1.6 | |
Distal of ICA bulb | 4 | 6.3 | |
ICA bulb origin | 3 | 4.6 | |
Proximal of ICA bulb | 2 | 3.1 | |
Post-bulbar ICA and bulb | 1 | 1.6 | |
Petrous ICA | 1 | 1.6 | |
Post-bulbar ICA | 4 | 6.3 | |
Plaque morphology | Short segment regular surfaced | 4 | 6.3 |
Short segment irregular surfaced | 2 | 3.2 | |
Short segment ulcerated | 2 | 3.2 | |
Long segment regular surfaced | 19 | 30.1 | |
Long segment irregular surfaced | 12 | 19.1 | |
Long segment ulcerated | 24 | 38.1 |
Table 4 Location and distribution by vascular territories of ischemic lesions which developed after carotid artery stenting based on diffusion-weighted imaging
Parameters | n | % |
Location of cerebral parenchymal lesion | ||
Occipital lobe | 11 | 28.2 |
Frontal lobe | 10 | 25.6 |
Parietal lobe | 8 | 20.5 |
Basal ganglions | 3 | 7.7 |
Cerebellum | 2 | 5.1 |
Frontoparietal | 1 | 2.6 |
Parietooccipital | 1 | 2.6 |
Frontoparietooccipital | 1 | 2.6 |
Occipitotemporoparietal | 1 | 2.6 |
Corpus callosum | 1 | 2.6 |
Cerebral vascular territory | ||
MCA | 15 | 38.5 |
PCA | 8 | 20.5 |
MCA-PCA “watershed” | 7 | 17.9 |
ACA | 3 | 7.7 |
ACA-MCA “watershed” | 2 | 5.1 |
ACA-MCA and MCA-PCA “watershed” | 2 | 5.1 |
PICA | 1 | 2.6 |
SCA | 1 | 2.6 |
Table 5 Technical properties, ischemic lesion numbers and complications in carotid artery stenting procedures
Case No. | Age | Gender | Stenosis localization | Balloon angioplasty | Embolic protection device | Ipsilateral lesion | Contralateral lesion | Complication |
3 | 59 | M | L ICA bulb | + | + | 5 | - | Silent ischemia |
6 | 71 | M | L ICA bulb | + | + | 1 | - | Silent ischemia |
8 | 72 | M | L ICA bulb | + | + | 3 | - | Silent ischemia |
9 | 71 | F | L ICA bulb | + | + | 2 | - | Silent ischemia |
11 | 78 | M | L ICA bulb | - | + | 3 | - | Silent ischemia |
13 | 72 | M | L ICA distal to bulb | + | + | 1 | - | Symptomatic ischemia |
15 | 71 | M | R ICA bulb | + | + | 1 | - | Silent ischemia |
16 | 62 | F | L ICA bulb | + | + | 4 | 3 | Silent ischemia |
17 | 75 | F | R ICA bulb | + | + | - | 1 | Silent ischemia |
19 | 68 | M | L post-bulbar ICA | + | + | 2 | - | Silent ischemia |
23 | 67 | M | R ICA bulb | + | + | 1 | - | Silent ischemia |
26 | 84 | M | L ICA bulb | + | + | - | 1 | Symptomatic ischemia |
29 | 76 | M | L post-bulbar ICA | + | + | 1 | - | Symptomatic ischemia |
36 | 70 | F | R ICA bulb | + | + | - | 1 | Silent ischemia |
38 | 76 | M | R ICA bulb | + | + | 1 | - | Silent ischemia |
46 | 74 | M | L ICA bulb | + | + | 3 | - | Silent ischemia |
52 | 68 | F | R ICA bulb | + | + | 1 | - | Symptomatic ischemia |
54 | 72 | F | R ICA bulb | + | + | 2 | - | Silent ischemia |
58 | 67 | M | R ICA bulb | + | + | 1 | - | Silent ischemia |
59 | 67 | M | L ICA bulb | + | + | 1 | - | Symptomatic ischemia |
Table 6 Time to symptom development, neurological symptoms and prognosis in symptomatic patients after carotid artery stenting
Case No. | Time to symptom development | Neurological symptoms | Prognosis |
13 | 1st hour | Loss of upper limb strength, right lower limb hemiparesis | Right upper limb muscle strength 4/5 |
26 | 5th hour | Restlessness, agitation | Recovery without sequelae |
29 | 19th hour | Motor aphasia, right upper limb muscle strength 2/5, plegia of right leg | Right upper limb muscle strength 4/5, dysdiadochokinesia |
52 | 22nd hour | Hemiparesis | Recovery without sequelae |
59 | 24th hour | Cloudy vision, vertigo, ataxia | Recovery without sequelae |
- Citation: Beyhan M, Acu B, Gökçe E, Fırat MM. Evaluation of ischemic lesions after carotid artery stenting with diffusion-weighted imaging. World J Clin Cases 2020; 8(10): 1859-1870
- URL: https://www.wjgnet.com/2307-8960/full/v8/i10/1859.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i10.1859